Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C ε transgenic mice by α-difluoromethylornithine accompanied by marked hair …

DL Wheeler, KJ Ness, TD Oberley, AK Verma - Cancer research, 2003 - AACR
DL Wheeler, KJ Ness, TD Oberley, AK Verma
Cancer research, 2003AACR
The role of 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated polyamine biosynthesis
in the development of metastatic squamous cell carcinoma (mSCC) in protein kinase C ε
(PKCε) transgenic mice was determined. TPA treatment induced epidermal ornithine
decarboxylase (ODC) activity and putrescine levels approximately 3–4-fold more in PKCε
transgenic mice than their wild-type littermates. Development of mSCC by the 7, 12-
dimethylbenz (a) anthracene (100 nmol)-TPA (5 nmol) protocol in PKCε transgenic mice was …
Abstract
The role of 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated polyamine biosynthesis in the development of metastatic squamous cell carcinoma (mSCC) in protein kinase C ε (PKCε) transgenic mice was determined. TPA treatment induced epidermal ornithine decarboxylase (ODC) activity and putrescine levels approximately 3–4-fold more in PKCε transgenic mice than their wild-type littermates. Development of mSCC by the 7,12-dimethylbenz(a)anthracene (100 nmol)-TPA (5 nmol) protocol in PKCε transgenic mice was completely prevented by administration of the suicide inhibitor of ODC α-difluoromethylornithine (DFMO, 0.5% w/v) in the drinking water during TPA promotion. However, DFMO treatment led to marked hair loss in PKCε transgenic mice. DFMO treatment-associated hair loss in PKCε transgenic mice was accompanied by a decrease in the number of intact hair follicles. These results indicate that TPA-induced ODC activity and the resultant accumulation of putrescine in PKCε transgenic mice are linked to growth and maintenance of hair follicles, and the development of mSCC. Severe hair loss observed in PKCε transgenic mice on DFMO during skin tumor promotion has not been reported before in the prevention of cancer in other animal models or in human cancer prevention trials.
AACR